Cellular rejuvenation: molecular mechanisms and potential therapeutic interventions for diseases

S Ji, M Xiong, H Chen, Y Liu, L Zhou, Y Hong… - … and Targeted Therapy, 2023 - nature.com
The ageing process is a systemic decline from cellular dysfunction to organ degeneration,
with more predisposition to deteriorated disorders. Rejuvenation refers to giving aged cells …

Germline risk of clonal haematopoiesis

AJ Silver, AG Bick, MR Savona - Nature Reviews Genetics, 2021 - nature.com
Clonal haematopoiesis (CH) is a common, age-related expansion of blood cells with
somatic mutations that is associated with an increased risk of haematological malignancies …

Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms

AK Jayavelu, TM Schnöder, F Perner, C Herzog… - Nature, 2020 - nature.com
Janus kinases (JAKs) mediate responses to cytokines, hormones and growth factors in
haematopoietic cells,. The JAK gene JAK2 is frequently mutated in the ageing …

The pathobiology of thrombosis, microvascular disease, and hemorrhage in the myeloproliferative neoplasms

HC Hasselbalch, M Elvers… - Blood, The Journal of the …, 2021 - ashpublications.org
Thrombotic, vascular, and bleeding complications are the most common causes of morbidity
and mortality in the Philadelphia chromosome–negative myeloproliferative neoplasms …

Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera

A Carobbio, AM Vannucchi, V De Stefano… - Blood cancer …, 2022 - nature.com
We investigated the neutrophil-to-lymphocyte ratio (NLR) as a predictor of thrombosis in
polycythemia vera (PV). After a median follow-up of 2.51 years, of 1508 PV patients enrolled …

JAK2V617F mutation is highly prevalent in patients with ischemic stroke: a case-control study

MH Kristiansen, L Kjær, V Skov, MK Larsen… - Blood …, 2023 - ashpublications.org
Ischemic stroke has a high recurrence rate despite treatment. This underlines the
significance of investigating new possible cerebrovascular risk factors, such as the acquired …

FLT3 inhibitors in acute myeloid leukemia: challenges and recent developments in overcoming resistance

Z Wang, J Cai, J Cheng, W Yang, Y Zhu… - Journal of Medicinal …, 2021 - ACS Publications
Mutations in the FMS-like tyrosine kinase 3 (FLT3) gene are often present in newly
diagnosed acute myeloid leukemia (AML) patients with an incidence rate of approximately …

DENR controls JAK2 translation to induce PD-L1 expression for tumor immune evasion

B Chen, J Hu, X Hu, H Chen, R Bao, Y Zhou… - Nature …, 2022 - nature.com
RNA-binding proteins (RBPs) can recognize thousands of RNAs that help to maintain cell
homeostasis, and RBP dysfunction is frequently observed in various cancers. However …

JAK-STAT inhibition reduces endothelial prothrombotic activation and leukocyte–endothelial proadhesive interactions

JD Beckman, A DaSilva, E Aronovich, A Nguyen… - Journal of Thrombosis …, 2023 - Elsevier
Background Vascular activation is characterized by increased proinflammatory, pro
thrombotic, and proadhesive signaling. Several chronic and acute conditions, including Bcr …

Rutin and selenium nanoparticles protected against STZ-induced diabetic nephropathy in rats through downregulating Jak-2/Stat3 pathway and upregulating Nrf-2/HO …

RA Zaghloul, AM Abdelghany, YA Samra - European Journal of …, 2022 - Elsevier
Diabetic nephropathy (DN) is a renal complication of diabetic hyperglycemia. The Signal
transducer and activator of transcription 3 (Stat3) is a center molecule of the chronic …